Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000804761 | SCV000944685 | uncertain significance | Spastic paraplegia | 2022-07-06 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with serine, which is neutral and polar, at codon 1484 of the ZFYVE26 protein (p.Arg1484Ser). This variant is present in population databases (rs368241137, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with ZFYVE26-related conditions. ClinVar contains an entry for this variant (Variation ID: 649757). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome Diagnostics Laboratory, |
RCV001849108 | SCV002106065 | uncertain significance | Hereditary spastic paraplegia | 2019-10-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002495094 | SCV002780087 | uncertain significance | Hereditary spastic paraplegia 15 | 2021-10-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002537183 | SCV003742462 | uncertain significance | Inborn genetic diseases | 2022-04-22 | criteria provided, single submitter | clinical testing | The c.4452G>C (p.R1484S) alteration is located in exon 22 (coding exon 21) of the ZFYVE26 gene. This alteration results from a G to C substitution at nucleotide position 4452, causing the arginine (R) at amino acid position 1484 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Mayo Clinic Laboratories, |
RCV003480840 | SCV004227315 | uncertain significance | not provided | 2022-06-06 | criteria provided, single submitter | clinical testing | BP4 |
Breakthrough Genomics, |
RCV003480840 | SCV005191437 | uncertain significance | not provided | criteria provided, single submitter | not provided |